Gowanlock Zachary, Lezhanska Anastasiya, Conroy Maeve, Crowther Mark, Tiboni Maria, Mbuagbaw Lawrence, Siegal Deborah M
Department of Medicine and.
Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, ON, Canada.
Blood Adv. 2020 Aug 11;4(15):3639-3647. doi: 10.1182/bloodadvances.2020001880.
Iron deficiency is a common consequence of bariatric surgery and frequently leads to anemia. Our study reports the incidence and predictors of iron deficiency, iron deficiency anemia (IDA), and IV iron use after bariatric surgery. We conducted a retrospective study of all adult patients who underwent bariatric surgery from January to December 2012 at the regional bariatric surgery center in Hamilton, Ontario, Canada, and were followed for at least 6 months. Time-to-event data were presented as Kaplan-Meier curves. Cox regression analysis was used to identify outcome predictors. A total of 388 patients met the inclusion criteria. Iron deficiency, IDA, and the use of IV iron were reported in 43%, 16%, and 6% of patients, respectively, with a mean follow-up of 31 months. The cumulative incidence of iron deficiency and IDA increased with longer follow-up, and there was a significant increase in IV iron use starting 3 years after surgery. Malabsorptive procedures (hazard ratio [HR], 1.92; 95% confidence interval [CI], 1.20-3.06; P = .006) and low baseline ferritin (HR, 0.96; 95% CI, 0.95-0.97; P < .001) were associated with an increased risk of iron deficiency. Young age (HR, 0.90; 95% CI, 0.82-0.99; P = .028), baseline anemia (HR, 19.6; 95% CI, 7.85-48.9; P < .001), and low baseline ferritin (HR, 0.96; 95% CI, 0.95-0.98; P < .001) were associated with an increased risk of IDA. Our results suggest that IDA is a delayed consequence of bariatric surgery and that preoperative assessment of patient risk may be possible.
缺铁是减肥手术的常见后果,常导致贫血。我们的研究报告了减肥手术后缺铁、缺铁性贫血(IDA)和静脉注射铁剂使用的发生率及预测因素。我们对2012年1月至12月在加拿大安大略省汉密尔顿地区减肥手术中心接受减肥手术且随访至少6个月的所有成年患者进行了一项回顾性研究。生存时间数据以Kaplan-Meier曲线表示。采用Cox回归分析来确定结果预测因素。共有388例患者符合纳入标准。分别有43%、16%和6%的患者报告有缺铁、IDA和使用静脉注射铁剂,平均随访时间为31个月。缺铁和IDA的累积发生率随随访时间延长而增加,术后3年开始静脉注射铁剂的使用显著增加。吸收不良手术(风险比[HR],1.92;95%置信区间[CI],1.20 - 3.06;P = 0.006)和低基线铁蛋白(HR,0.96;95% CI,0.95 - 0.97;P < 0.001)与缺铁风险增加相关。年轻(HR,0.90;95% CI,0.82 - 0.99;P = 0.028)、基线贫血(HR,19.6;95% CI,7.85 - 48.9;P < 0.001)和低基线铁蛋白(HR,0.96;95% CI,0.95 - 0.98;P < 0.001)与IDA风险增加相关。我们的结果表明,IDA是减肥手术的延迟后果,术前评估患者风险可能是可行的。